About Avita Medical
Avita Medical is a publicly listed, global medical technology company trading on the Australian Stock Exchange (ASX:AVH) and OTC Markets (OTCQX:AVMXY). The company develops and distributes highly innovative products in Regenerative and Respiratory Medicine. The company’s regenerative and tissue-engineered products provide revolutionary solutions utilising the patient’s own skin and the regenerative capability of the human body to treat a wide range of wounds, scars and skin The Regenerative group of products use innovative technology to harness the most effective means of wound healing and skin regeneration – healthy skin. Regenerative technology uses the patient’s own skin as a natural laboratory to provide a suspension of skin cells and growth factors to heal wounds and improve the appearance of damaged skin. The Regenerative group of products includes ReCell for the treatment of burns, RenovaCell for plastics, aesthetic and Maxillo-Facial procedures and RegenerCell for the treatment of lower leg chronic wounds.